Vancouver, BC – May 13, 2021 – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (NASDAQ:INM), a clinical-stage company developing pharmaceutical-based drug candidates and leading the way in the clinical development… Read More
SEATTLE, WA– (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook… Read More
According to our new research study on “Organoids Market to 2027 – Global Analysis and Forecast – by Type, Application, and Source,” the organoids market was valued at US$ 689.47… Read More
PENTICTON, British Columbia & SAN DIEGO − May 10, 2021 (Newswire.com) – XCO Tech Inc. and Atlazo, Inc. have announced the formation of Recon Health Inc., a joint venture to commercialize… Read More
Early identification of unique cell markers is expected to have valuable impact on patents, clinical efficacy, and manufacturing optimization VANCOUVER, BC – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)… Read More
